Search research articles
Contact Us
Filters
Showing results (371-380 of 393) with videos related to
Page
of 40
Sort By:
The Journal of Infectious Diseases
|
November 24, 2019
Live Respiratory Syncytial Virus Attenuated by M2-2 Deletion and Stabilized Temperature Sensitivity Mutation 1030s Is a Promising Vaccine Candidate in Children
Elizabeth J McFarland, Ruth A Karron, Petronella Muresan, et al.
The Journal of Infectious Diseases
|
February 2, 2020
Live-Attenuated Respiratory Syncytial Virus Vaccine With M2-2 Deletion and With Small Hydrophobic Noncoding Region Is Highly Immunogenic in Children
Elizabeth J McFarland, Ruth A Karron, Petronella Muresan, et al.
The Lancet. HIV
|
April 15, 2024
Pharmacokinetics and safety of coformulated bictegravir, emtricitabine, and tenofovir alafenamide in children aged 2 years and older with virologically suppressed HIV: a phase 2/3, open-label, single-arm study
Carina A Rodriguez, Eva Natukunda, Renate Strehlau, et al.
The Journal of Infectious Diseases
|
March 7, 2018
Live-Attenuated Respiratory Syncytial Virus Vaccine Candidate With Deletion of RNA Synthesis Regulatory Protein M2-2 is Highly Immunogenic in Children
Elizabeth J McFarland, Ruth A Karron, Petronella Muresan, et al.
The Pediatric Infectious Disease Journal
|
April 12, 2017
The Nasopharyngeal Microbiota of Children With Respiratory Infections in Botswana
Matthew S Kelly, Michael G Surette, Marek Smieja, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
January 28, 2004
The metabolic disposition of aprepitant, a substance P receptor antagonist, in rats and dogs
Su-Er W Huskey, Brian J Dean, George A Doss, et al.
Journal of Clinical Immunology
|
May 19, 2016
Hyper IgM Syndrome: a Report from the USIDNET Registry
Emily A Leven, Patrick Maffucci, Hans D Ochs, et al.
Journal of Virology
|
March 5, 2010
Phenotypic and functional profile of HIV-inhibitory CD8 T cells elicited by natural infection and heterologous prime/boost vaccination
Stephanie A Freel, Laurie Lamoreaux, Pratip K Chattopadhyay, et al.
The Journal of Infectious Diseases
|
May 19, 2021
Safety, Tolerability, and Pharmacokinetics of a Long-Acting Broadly Neutralizing Human Immunodeficiency Virus Type 1 (HIV-1) Monoclonal Antibody VRC01LS in HIV-1-Exposed Newborn Infants
Elizabeth J McFarland, Coleen K Cunningham, Petronella Muresan, et al.
Journal of Medicinal Chemistry
|
May 30, 1998
A potent, orally bioavailable benzazepinone growth hormone secretagogue
R J DeVita, R Bochis, A J Frontier, et al.
Page
of 40
Search research articles
Search
Showing results (371-380 of 393) with videos related to
Sort By:
Page
of 40
The Journal of Infectious Diseases
|
November 24, 2019
Live Respiratory Syncytial Virus Attenuated by M2-2 Deletion and Stabilized Temperature Sensitivity Mutation 1030s Is a Promising Vaccine Candidate in Children
Elizabeth J McFarland, Ruth A Karron, Petronella Muresan, et al.
The Journal of Infectious Diseases
|
February 2, 2020
Live-Attenuated Respiratory Syncytial Virus Vaccine With M2-2 Deletion and With Small Hydrophobic Noncoding Region Is Highly Immunogenic in Children
Elizabeth J McFarland, Ruth A Karron, Petronella Muresan, et al.
The Lancet. HIV
|
April 15, 2024
Pharmacokinetics and safety of coformulated bictegravir, emtricitabine, and tenofovir alafenamide in children aged 2 years and older with virologically suppressed HIV: a phase 2/3, open-label, single-arm study
Carina A Rodriguez, Eva Natukunda, Renate Strehlau, et al.
The Journal of Infectious Diseases
|
March 7, 2018
Live-Attenuated Respiratory Syncytial Virus Vaccine Candidate With Deletion of RNA Synthesis Regulatory Protein M2-2 is Highly Immunogenic in Children
Elizabeth J McFarland, Ruth A Karron, Petronella Muresan, et al.
The Pediatric Infectious Disease Journal
|
April 12, 2017
The Nasopharyngeal Microbiota of Children With Respiratory Infections in Botswana
Matthew S Kelly, Michael G Surette, Marek Smieja, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
January 28, 2004
The metabolic disposition of aprepitant, a substance P receptor antagonist, in rats and dogs
Su-Er W Huskey, Brian J Dean, George A Doss, et al.
Journal of Clinical Immunology
|
May 19, 2016
Hyper IgM Syndrome: a Report from the USIDNET Registry
Emily A Leven, Patrick Maffucci, Hans D Ochs, et al.
Journal of Virology
|
March 5, 2010
Phenotypic and functional profile of HIV-inhibitory CD8 T cells elicited by natural infection and heterologous prime/boost vaccination
Stephanie A Freel, Laurie Lamoreaux, Pratip K Chattopadhyay, et al.
The Journal of Infectious Diseases
|
May 19, 2021
Safety, Tolerability, and Pharmacokinetics of a Long-Acting Broadly Neutralizing Human Immunodeficiency Virus Type 1 (HIV-1) Monoclonal Antibody VRC01LS in HIV-1-Exposed Newborn Infants
Elizabeth J McFarland, Coleen K Cunningham, Petronella Muresan, et al.
Journal of Medicinal Chemistry
|
May 30, 1998
A potent, orally bioavailable benzazepinone growth hormone secretagogue
R J DeVita, R Bochis, A J Frontier, et al.
Page
of 40